Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 2
1990 1
1991 1
1992 1
1993 1
1995 1
1996 1
2000 1
2003 1
2004 1
2005 1
2006 2
2007 2
2008 2
2009 1
2010 2
2011 6
2012 1
2013 2
2014 5
2015 5
2016 7
2017 12
2018 22
2019 18
2020 21
2021 22
2022 25
2023 25
2024 22
2025 29
2026 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

219 results

Results by year

Filters applied: . Clear all
Page 1
Variants in CFAP410 cause a range of retinal and skeletal phenotypes.
Schmidt RE, Pohodich AE, Birch D, Jones K, Lam BL, Jung EH, Jain N, Georgiou M, Mahroo OA, Webster AR, Michaelides M, Bakall B, Iannaccone A, Vincent A, Parameswarappa DC, Heon E, Scholl HPN, Janeschitz-Kriegl L, Traboulsi EI, Zein W, Brooks BP, Cukras C, Hufnagel R, Aleman TS, Sylla MM, Tsang SH, Alabek M, Sahel J, Gorin MB, van Genderen MM, Stingl K, Reith M, Kohl S, Amaral RAS, Sallum JMF, Vincent AL, Hull S, Duncan JL, Hanson JVM, Tedeus M, Maggi J, Graf U, Koller S, Berger W, Gerth-Kahlert C, Marra M, Everett LA, Yang P, Pennesi ME. Schmidt RE, et al. Among authors: jung eh. NPJ Genom Med. 2025 Apr 17;10(1):32. doi: 10.1038/s41525-025-00489-1. NPJ Genom Med. 2025. PMID: 40246852 Free PMC article.
Guiding first-line treatment decisions in advanced urothelial carcinoma: a global survey.
Grande E, Bellmunt J, Hussain SA, Al Mansour MM, Bamias A, Barthélémy P, Benjamin DJ, Blais N, Bourlon MT, Castellano D, Danchaivijitr P, Fernandez Lazzaro M, Giannatempo P, Guerrero-Ramos F, Iacovelli R, Ivanyi P, Jung EH, Kanesvaran R, Manneh R, Marinho JC, Matsubara N, Merseburger AS, Mukherji D, Park CH, Tran B, da Trindade KM, Ürün Y, Kamat AM, Birtle AJ. Grande E, et al. Among authors: jung eh. Oncologist. 2025 Oct 1;30(10):oyaf333. doi: 10.1093/oncolo/oyaf333. Oncologist. 2025. PMID: 41052287 Free PMC article.
Colopathy associated with pentosan polysulfate use.
Jung EH, Zheng W, Weiss RJ, Mathew NE, Meyer BI, Nizam A, Iskandar H, Jain N. Jung EH, et al. Front Pharmacol. 2025 Jul 28;16:1494467. doi: 10.3389/fphar.2025.1494467. eCollection 2025. Front Pharmacol. 2025. PMID: 40792210 Free PMC article.
Challenges and Opportunities for Biomarker Validation.
Hey SP, D'Andrea E, Jung EH, Tessema F, Luo J, Gyawali B, Kesselheim AS. Hey SP, et al. Among authors: jung eh. J Law Med Ethics. 2019 Sep;47(3):357-361. doi: 10.1177/1073110519876162. J Law Med Ethics. 2019. PMID: 31560620
FDA and EMA Biosimilar Approvals.
Jung EH, Sarpatwari A, Kesselheim AS, Sinha MS. Jung EH, et al. J Gen Intern Med. 2020 Jun;35(6):1908-1910. doi: 10.1007/s11606-019-05408-6. Epub 2019 Oct 21. J Gen Intern Med. 2020. PMID: 31637641 Free PMC article. No abstract available.
VEGFR2 blockade overcomes acquired KRAS G12D inhibitor resistance driven by PI3Kγ activation.
Hwang SH, Bae M, Kim JW, Hyun SY, Kim KJ, Choe JH, Kim MJ, Park JW, Jeong SY, Choi S, Park W, Seo J, Chae H, Kang M, Jung EH, Suh KJ, Kim SH, Kim JW, Kim YJ, Kim JH, Park H, Aguirre AJ, Lee EA, Ku JL, Lee KW. Hwang SH, et al. Among authors: jung eh. bioRxiv [Preprint]. 2025 Sep 18:2025.09.16.676456. doi: 10.1101/2025.09.16.676456. bioRxiv. 2025. PMID: 41000780 Free PMC article. Preprint.
219 results